Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥90% predicted at baseline

Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥90% predicted at baseline

Resource Type

CF Research News

Authors

BL Aalbers, KM de Winter-de Groot, HGM Arets, RW Hofland, AC de Kiviet, MMM van Oirschot-van de Ven, MA Kruijswijk, S Schotman, S Michel, CK van der Ent, HGM Heijerman

References

J Cyst Fibros 2020 Jan 7 - DOI: 10.1016/j.jcf.2019.12.015

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Date

Tuesday, January 7, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [3]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/clinical-effect-lumacaftorivacaftor-f508del-homozygous-cf-patients

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00374R2_FINAL_Aalbers_260220.pdf [2] https://pubmed.ncbi.nlm.nih.gov/?term=Clinical%20effect%20of%20lumacaftor/ivacaftor%20in%20F508del%20homozygous%20CF%20patients%20with%20FEV1%20%E2%89%A590%25%20predicted%20at%20baseline [3] https://www.ecfs.eu/resource-guideline-type/other-guidelines